Indian 
pharma Companies ( Ranbaxy Laboratories Ltd., Cipla Ltd. and Aurobindo Pharma) will now have the opportunity to gain from Brazil’s move to breach the patent on Merck & Co. Inc.’s AIDS drug. Brazilian President, Luiz Inacio Lula da Silva, allowed Brazil to break the patent, and in turn, get a generic version from India. From this move Aurobindo Pharma is anticipating gains in the region of $50 million, as informed by its Chairman P. V. Ramaprasad Reddy. The patent was detoured by Brazil after the Health Ministry rejected New Jersey-based Merck’s offer to reduce the price of its pills by 30%.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2007
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
For More IIPM Article, Visit Below....
http://iipm-top-mba-institute.spaces.live.com/
http://iipm-here-is-your-future.spaces.live.com/
http://iipm-campus-events.spaces.live.com/
http://iipm-institute.spaces.live.com/
pharma Companies ( Ranbaxy Laboratories Ltd., Cipla Ltd. and Aurobindo Pharma) will now have the opportunity to gain from Brazil’s move to breach the patent on Merck & Co. Inc.’s AIDS drug. Brazilian President, Luiz Inacio Lula da Silva, allowed Brazil to break the patent, and in turn, get a generic version from India. From this move Aurobindo Pharma is anticipating gains in the region of $50 million, as informed by its Chairman P. V. Ramaprasad Reddy. The patent was detoured by Brazil after the Health Ministry rejected New Jersey-based Merck’s offer to reduce the price of its pills by 30%.For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2007
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
For More IIPM Article, Visit Below....
http://iipm-top-mba-institute.spaces.live.com/
http://iipm-here-is-your-future.spaces.live.com/
http://iipm-campus-events.spaces.live.com/
http://iipm-institute.spaces.live.com/
No comments:
Post a Comment